These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 38679971)
1. Regulation of Hypoxia Dependent Reprogramming of Cancer Metabolism: Role of HIF-1 and Its Potential Therapeutic Implications in Leukemia. Pandey S; Singh R; Habib N; Tripathi RM; Kushwaha R; Mahdi AA Asian Pac J Cancer Prev; 2024 Apr; 25(4):1121-1134. PubMed ID: 38679971 [TBL] [Abstract][Full Text] [Related]
2. HIF-1 mediated metabolic reprogramming in cancer: Mechanisms and therapeutic implications. Taneja N; Chauhan A; Kulshreshtha R; Singh S Life Sci; 2024 Sep; 352():122890. PubMed ID: 38971364 [TBL] [Abstract][Full Text] [Related]
3. Lipid metabolic reprogramming by hypoxia-inducible factor-1 in the hypoxic tumour microenvironment. Seo J; Yun JE; Kim SJ; Chun YS Pflugers Arch; 2022 Jun; 474(6):591-601. PubMed ID: 35348849 [TBL] [Abstract][Full Text] [Related]
4. Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target. Infantino V; Santarsiero A; Convertini P; Todisco S; Iacobazzi V Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071836 [TBL] [Abstract][Full Text] [Related]
5. 14-3-3ζ up-regulates hypoxia-inducible factor-1α in hepatocellular carcinoma via activation of PI3K/Akt/NF-кB signal transduction pathway. Tang Y; Lv P; Sun Z; Han L; Luo B; Zhou W Int J Clin Exp Pathol; 2015; 8(12):15845-53. PubMed ID: 26884855 [TBL] [Abstract][Full Text] [Related]
6. HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer. Huang Y; Chen Z; Lu T; Bi G; Li M; Liang J; Hu Z; Zheng Y; Yin J; Xi J; Lin Z; Zhan C; Jiang W; Wang Q; Tan L J Exp Clin Cancer Res; 2021 Dec; 40(1):398. PubMed ID: 34930376 [TBL] [Abstract][Full Text] [Related]
7. Knockdown of Hypoxia-Inducible Factor 1α (HIF-1α) Promotes Autophagy and Inhibits Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Ovarian Cancer Cells. Huang J; Gao L; Li B; Liu C; Hong S; Min J; Hong L Med Sci Monit; 2019 Jun; 25():4250-4263. PubMed ID: 31175269 [TBL] [Abstract][Full Text] [Related]
8. Identification and Development of Cyclic Peptide Inhibitors of Hypoxia Inducible Factors 1 and 2 That Disrupt Hypoxia-Response Signaling in Cancer Cells. Ball AT; Mohammed S; Doigneaux C; Gardner RM; Easton JW; Turner S; Essex JW; Pairaudeau G; Tavassoli A J Am Chem Soc; 2024 Apr; 146(13):8877-8886. PubMed ID: 38503564 [TBL] [Abstract][Full Text] [Related]
9. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia. Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816 [TBL] [Abstract][Full Text] [Related]
10. Effect of hypoxia-inducible factors in normal and leukemic stem cell regulation and their potential therapeutic impact. Rouault-Pierre K; Hamilton A; Bonnet D Expert Opin Biol Ther; 2016; 16(4):463-76. PubMed ID: 26679619 [TBL] [Abstract][Full Text] [Related]
11. Activation of the hypoxia-inducible factor pathway protects against acute ischemic stroke by reprogramming central carbon metabolism. Madai S; Kilic P; Schmidt RM; Bas-Orth C; Korff T; Büttner M; Klinke G; Poschet G; Marti HH; Kunze R Theranostics; 2024; 14(7):2856-2880. PubMed ID: 38773968 [TBL] [Abstract][Full Text] [Related]
12. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway. Gong T; Cui L; Wang H; Wang H; Han N J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734 [TBL] [Abstract][Full Text] [Related]
13. The dual role of MiR-210 in the aetiology of cancer: A focus on hypoxia-inducible factor signalling. Afsar S; Syed RU; Bin Break MK; Alsukaybi RH; Alanzi RA; Alshobrmi AM; Alshagdali NM; Alshammari AD; Alharbi FM; Alshammari AM; Algharbi WF; Albrykan KM; Alshammari FN Pathol Res Pract; 2024 Jan; 253():155018. PubMed ID: 38070222 [TBL] [Abstract][Full Text] [Related]
14. Keeping the engine primed: HIF factors as key regulators of cardiac metabolism and angiogenesis during ischemia. Shohet RV; Garcia JA J Mol Med (Berl); 2007 Dec; 85(12):1309-15. PubMed ID: 18026917 [TBL] [Abstract][Full Text] [Related]
15. The hypoxia-inducible factor (HIF) couples immunity with metabolism. Halligan DN; Murphy SJ; Taylor CT Semin Immunol; 2016 Oct; 28(5):469-477. PubMed ID: 27717536 [TBL] [Abstract][Full Text] [Related]
16. [Research progress of hypoxia-inducible factor 1 inhibitors against tumors]. Niu F; Li Y; Lai FF; Chen XG Yao Xue Xue Bao; 2014 Jun; 49(6):832-6. PubMed ID: 25212028 [TBL] [Abstract][Full Text] [Related]
17. Bortezomib represses HIF-1α protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells. Befani CD; Vlachostergios PJ; Hatzidaki E; Patrikidou A; Bonanou S; Simos G; Papandreou CN; Liakos P J Mol Med (Berl); 2012 Jan; 90(1):45-54. PubMed ID: 21909688 [TBL] [Abstract][Full Text] [Related]
18. The intravenous anesthetic propofol inhibits lipopolysaccharide-induced hypoxia-inducible factor 1 activation and suppresses the glucose metabolism in macrophages. Tanaka T; Takabuchi S; Nishi K; Oda S; Wakamatsu T; Daijo H; Fukuda K; Hirota K J Anesth; 2010 Feb; 24(1):54-60. PubMed ID: 20039079 [TBL] [Abstract][Full Text] [Related]
19. Natural compounds and the hypoxia-inducible factor (HIF) signalling pathway. Manolescu B; Oprea E; Busu C; Cercasov C Biochimie; 2009; 91(11-12):1347-58. PubMed ID: 19703512 [TBL] [Abstract][Full Text] [Related]
20. Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment. Frolova O; Samudio I; Benito JM; Jacamo R; Kornblau SM; Markovic A; Schober W; Lu H; Qiu YH; Buglio D; McQueen T; Pierce S; Shpall E; Konoplev S; Thomas D; Kantarjian H; Lock R; Andreeff M; Konopleva M Cancer Biol Ther; 2012 Aug; 13(10):858-70. PubMed ID: 22785211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]